meclizine has been researched along with Parkinson Disease in 1 studies
Meclizine: A histamine H1 antagonist used in the treatment of motion sickness, vertigo, and nausea during pregnancy and radiation sickness.
Parkinson Disease: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Meclizine is a well-tolerated drug routinely used as an anti-histamine agent in the management of disequilibrium." | 5.43 | Meclizine-induced enhanced glycolysis is neuroprotective in Parkinson disease cell models. ( Chau, KY; Hong, CT; Schapira, AH, 2016) |
| "Meclizine is a well-tolerated drug routinely used as an anti-histamine agent in the management of disequilibrium." | 1.43 | Meclizine-induced enhanced glycolysis is neuroprotective in Parkinson disease cell models. ( Chau, KY; Hong, CT; Schapira, AH, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hong, CT | 1 |
| Chau, KY | 1 |
| Schapira, AH | 1 |
1 other study available for meclizine and Parkinson Disease
| Article | Year |
|---|---|
Meclizine-induced enhanced glycolysis is neuroprotective in Parkinson disease cell models.
Topics: Animals; Apoptosis; Cell Line; Fructosediphosphates; Gene Expression Regulation; Glycolysis; Humans; | 2016 |